Breaking tolerance: the autoimmune aspect of atherosclerosis

Wolf, D. & Ley, K. Immunity and inflammation in atherosclerosis. Circ. Res. 124, 315–327 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsao, C. W. et al. Heart Disease and Stroke Statistics — 2023 update: a report from the American Heart Association. Circulation 147, e93–e621 (2023).

Article  PubMed  Google Scholar 

Michos, E. D., McEvoy, J. W. & Blumenthal, R. S. Lipid management for the prevention of atherosclerotic cardiovascular disease. N. Engl. J. Med. 381, 1557–1567 (2019).

Article  CAS  PubMed  Google Scholar 

Kobiyama, K. & Ley, K. Atherosclerosis. Circ. Res. 123, 1118–1120 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008).

Article  CAS  PubMed  Google Scholar 

Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).

Article  CAS  PubMed  Google Scholar 

Tardif, J. C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381, 2497–2505 (2019).

Article  CAS  PubMed  Google Scholar 

Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A. & Thompson, P. L. Low-dose colchicine for secondary prevention of cardiovascular disease. J. Am. Coll. Cardiol. 61, 404–410 (2013).

Article  CAS  PubMed  Google Scholar 

Tsimikas, S., Palinski, W. & Witztum, J. L. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 95–100 (2001).

Article  CAS  PubMed  Google Scholar 

Tsimikas, S. et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48, 425–433 (2007).

Article  CAS  PubMed  Google Scholar 

Wang, Z. et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat. Cardiovasc. Res. 2, 290–306 (2023).

Article  ADS  PubMed  PubMed Central  Google Scholar 

Depuydt, M. A. C. et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat. Cardiovasc. Res. 2, 112–125 (2023).

Article  Google Scholar 

Saigusa, R., Winkels, H. & Ley, K. T cell subsets and functions in atherosclerosis. Nat. Rev. Cardiol. 17, 387–401 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Che, J. et al. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score. Cardiol. J. 18, 364–370 (2011).

PubMed  Google Scholar 

Gruzdeva, O. et al. Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction. Lipids Health Dis. 13, 111 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Chen, Q. et al. Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women’s Ischemia Syndrome Evaluation study. J. Lipid Res. 52, 801–807 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garrido-Sánchez, L., Chinchurreta, P., García-Fuentes, E., Mora, M. & Tinahones, F. J. A higher level of IgM anti-oxidized LDL antibodies is associated with a lower severity of coronary atherosclerosis in patients on statins. Int. J. Cardiol. 145, 263–264 (2010).

Article  PubMed  Google Scholar 

Soto, Y. et al. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease. Hum. Antib. 18, 109–117 (2009).

Article  CAS  Google Scholar 

van den Berg, V. J. et al. IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3). EBioMedicine 36, 63–72 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Que, X. et al. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558, 301–306 (2018).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Wolf, D. et al. Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B100-reactive CD4+ T-regulatory cells. Circulation 142, 1279–1293 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roy, P. et al. Immunodominant MHC-II (major histocompatibility complex II) restricted epitopes in human apolipoprotein B. Circ. Res. 131, 258–276 (2022).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Wick, G., Knoflach, M. & Xu, Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22, 361–403 (2004).

Article  CAS  PubMed  Google Scholar 

Saigusa, R. et al. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat. Cardiovasc. Res. 1, 462–475 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Bentzon, J. F., Otsuka, F., Virmani, R. & Falk, E. Mechanisms of plaque formation and rupture. Circ. Res. 114, 1852–1866 (2014).

Article  CAS  PubMed  Google Scholar 

Koltsova, E. K. et al. Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J. Clin. Invest. 122, 3114–3126 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martel, C. et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J. Clin. Invest. 123, 1571–1579 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iqneibi, S. et al. Single cell transcriptomics reveals recent CD8T cell receptor signaling in patients with coronary artery disease. Front. Immunol. 14, 1239148 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freuchet, A. et al. Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T cells. Nat. Immunol. 24, 1748–1761 (2023).

Article  CAS  PubMed  Google Scholar 

Butcher, M. J. et al. Atherosclerosis-driven Treg plasticity results in formation of a dysfunctional subset of plastic IFNγ+ Th1/Tregs. Circ. Res. 119, 1190–1203 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, J. et al. CCR5+T-bet+FoxP3+ effector CD4 T cells drive atherosclerosis. Circ. Res. 118, 1540–1552 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaddis, D. E. et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat. Commun. 9, 1095 (2018).

Article  ADS  PubMed  PubMed Central  Google Scholar 

Kimura, T. et al. Regulatory CD4+ T cells recognize major histocompatibility complex class II molecule-restricted peptide epitopes of apolipoprotein B. Circulation 138, 1130–1143 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali, A. J., Makings, J. & Ley, K. Regulatory T cell stability and plasticity in atherosclerosis. Cells 9, 2665 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667–1671 (2010).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423–431 (2007).

Article  CAS 

留言 (0)

沒有登入
gif